Gene: ELL2
Official Full Name: elongation factor for RNA polymerase II 2provided by HGNC
Gene Summary: Predicted to enable cis-regulatory region sequence-specific DNA binding activity. Involved in snRNA transcription by RNA polymerase II. Located in nucleoplasm. Part of transcription elongation factor complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30105 | ELL2 Knockout cell line (HeLa) | Human | ELL2 | 1:3~1:6 | Negative | Online Inquiry |
KO30106 | ELL2 Knockout cell line (HCT 116) | Human | ELL2 | 1:2~1:4 | Negative | Online Inquiry |
KO30107 | ELL2 Knockout cell line (HEK293) | Human | ELL2 | 1:3~1:6 | Negative | Online Inquiry |
KO30108 | ELL2 Knockout cell line (A549) | Human | ELL2 | 1:3~1:4 | Negative | Online Inquiry |
ELL2 Gene Knockout Cell Lines are engineered cellular models specifically designed to study the biological roles and functions of the ELL2 gene. This gene is involved in various cellular processes, including transcription regulation and response to DNA damage. By providing a platform where the ELL2 gene is functionally disrupted, these knockout cell lines enable scientists to investigate the phenotypic consequences of ELL2 deficiency, both at the molecular and cellular levels.
The primary mechanism of action of ELL2 gene knockout cell lines involves the complete ablation of ELL2 gene expression, achieved through CRISPR/Cas9 gene-editing technology or other gene-inactivation methods. This loss of function allows researchers to delineate the pathways and downstream effectors influenced by ELL2, facilitating a deeper understanding of its role in cellular pathways, oncogenesis, and potential therapeutic resistance mechanisms.
The scientific importance of these cell lines cannot be overstated, as they have applications in fundamental research, drug discovery, and the development of targeted therapies. Researchers can utilize ELL2 knockout cell lines to ascertain the effects of pharmacological agents, gene interactions, or environmental stressors on cellular behavior without the confounding influence of functional ELL2 protein.
In comparison to alternative cell lines that may harbor the ELL2 gene, our knockout variants provide an unambiguous system for investigating loss-of-function effects. This specificity reduces the variables in experimental design, yielding clearer, more reliable data.
For researchers and clinicians, these cell lines represent an invaluable resource in the quest to unravel the complexities of gene regulation and its implications for disease. The ability to simulate genetic deficiencies in a controlled environment positions ELL2 knockout cell lines as essential tools in translational research.
Our company prides itself on its commitment to advancing biological research tools. We leverage cutting-edge technologies to produce high-quality, reliable genetic models that empower scientists to push the boundaries of knowledge in gene function and disease mechanisms.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.